Bandingkan Harga & Kinerja Multi Spunindo Jaya Tbk. (MSJA) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Multi Spunindo Jaya Tbk. dan Tempo Scan Pacific Tbk.: Multi Spunindo Jaya Tbk. diperdagangkan di Rp825 (kapitalisasi pasar 5,24 T, volume 24 jam 16,9 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.730 (kapitalisasi pasar 12,36 T, volume 24 jam 1,41 jt). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 2,4× kapitalisasi pasar Multi Spunindo Jaya Tbk., dan Multi Spunindo Jaya Tbk. lebih aktif diperdagangkan (16,9 jt vs 1,41 jt). Mana yang lebih baik tergantung tujuan investasimu.
| MSJA | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 5,24 T | 12,36 T |
Volume | 16,9 jt | 1,41 jt |
Lot | 169,01 rb | 14,08 rb |
Perputaran | 13,99 M | 3,83 M |
Harga Rata-rata | 827,58 | 2.722,04 |
Nilai Transaksi | 13,99 M | 3,83 M |
Harga Ekuilibrium Indikatif | 825 | 2.730 |
Volume Ekuilibrium Indikatif | 1,8 rb | 2,51 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Multi Spunindo Jaya Tbk.
PT Multi Spunindo Jaya Tbk (the Company), was established based on Notarial Deed of WahyudiSuyanto, S.H., No. 102 dated March 7, 1997. The Company started its commercial operation in 1999. The Company’s immediate parent company is PT Maju Selaras Jayamerta and the ultimate controlling shareholder of the Company is Sasongko Basuki.
Selengkapnya di halaman MSJA →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
